about
Purinergic signalling and cancerPurinergic signaling and human immunodeficiency virus/acquired immune deficiency syndrome: From viral entry to therapyPurinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responsesPrinciples and properties of ion flow in P2X receptorsMolecularly and clinically related drugs and diseases are enriched in phenotypically similar drug-disease pairsInsights into the Molecular Mechanisms Underlying Mammalian P2X7 Receptor Functions and Contributions in Diseases, Revealed by Structural Modeling and Single Nucleotide PolymorphismsP2X7 targeting inhibits growth of human mesotheliomaHigh MUC2 expression in ovarian cancer is inversely associated with the M1/M2 ratio of tumor-associated macrophages and patient survival timeMultidrug Resistance-Associated Protein 2 Expression Is Upregulated by Adenosine 5'-Triphosphate in Colorectal Cancer Cells and Enhances Their Survival to Chemotherapeutic DrugsDifferentiating connexin hemichannels and pannexin channels in cellular ATP release.Staphylococcus aureus alpha-toxin mediates general and cell type-specific changes in metabolite concentrations of immortalized human airway epithelial cells.Transcriptomic analysis of differentially expressed genes in the Ras1(CA)-overexpressed and wildtype posterior silk glandsThe P2Y2 nucleotide receptor mediates the proliferation and migration of human hepatocellular carcinoma cells induced by ATP.ATP-P2Y2-β-catenin axis promotes cell invasion in breast cancer cellsCarcinoma-specific expression of P2Y11 receptor and its contribution in ATP-induced purinergic signalling and cell migration in human hepatocellular carcinoma cells.Purinergic signaling in early inflammatory events of the foreign body response: modulating extracellular ATP as an enabling technology for engineered implants and tissuesLiver X receptor β activation induces pyroptosis of human and murine colon cancer cellsAdenosine uptake is the major effector of extracellular ATP toxicity in human cervical cancer cells.Looking in the Porphyromonas gingivalis cabinet of curiosities: the microbium, the host and cancer associationComparative genomic and expression analysis of the adenosine signaling pathway members in XenopusA functional landscape of resistance to ALK inhibition in lung cancer.P2X7 mediates ATP-driven invasiveness in prostate cancer cells.P2X7 receptor predicts postoperative cancer-specific survival of patients with clear-cell renal cell carcinoma.How interacting pathways are regulated by miRNAs in breast cancer subtypes.Effect of P2X4R on airway inflammation and airway remodeling in allergic airway challenge in mice.Extracellular ATP and other nucleotides-ubiquitous triggers of intercellular messenger release.L-Lactate protects neurons against excitotoxicity: implication of an ATP-mediated signaling cascade.Galunisertib inhibits glioma vasculogenic mimicry formation induced by astrocytes.Extracellular purines promote the differentiation of human bone marrow-derived mesenchymal stem cells to the osteogenic and adipogenic lineages.Detecting adenosine triphosphate in the pericellular space.Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death.D-serine in the midbrain periaqueductal gray contributes to morphine tolerance in rats.P2Y2 receptor promotes cell invasion and metastasis in prostate cancer cellsSubfailure Overstretch Injury Leads to Reversible Functional Impairment and Purinergic P2X7 Receptor Activation in Intact Vascular TissueIL-1α and IL-1β-producing macrophages populate lung tumor lesions in miceHigh expression of ecto-nucleotidases CD39 and CD73 in human endometrial tumors.Nucleotides and nucleoside signaling in the regulation of the epithelium to mesenchymal transition (EMT).ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment.Bacterial Carriers for Glioblastoma TherapyCell volume regulation in epithelial physiology and cancer
P2860
Q24618782-F35C65BB-8180-4671-8274-A149C1937752Q26797749-5D9B7D18-2ED8-41F2-BBC9-C8C69A8135F4Q26863398-C632B3CB-9041-4FF1-B8C7-1E9004A2F415Q27021363-F2D827E5-3CFC-421A-9142-AA224F748585Q27499827-F51CECFE-EB67-4FA5-84DA-6B14D16A7298Q27500422-147F29B7-AEAC-4398-82E7-0CFAC6F2DBAAQ28468633-68DDA565-FCCC-4478-ABA2-2F5A187405A0Q28536347-54FCFE57-A549-4FD3-8459-4C101605A23EQ28547426-4E1A0D24-1EE9-46A8-AF1A-7D6CBB63A2E6Q30405751-81278E73-17C9-4DDB-BEF4-99B1227073E8Q30440120-433785FA-723C-4F08-B361-0F87F5DEE304Q33642190-96751D5D-5EAF-4661-9680-2849DBDDBE5BQ33846541-FB9CDE48-DC50-4D96-AFD5-995FC3789129Q33873659-8AD7A539-2996-419B-B607-8B7D9408BA9DQ33913908-5EFABA49-61DB-4C9A-B009-1457085A1563Q34290997-1C5E377B-EEA4-46FC-87A2-9F19229C99C1Q34486432-FD71EACE-D719-4560-B85C-A7F8BD10A70DQ34504024-B9763B27-F99D-47C3-8353-F9C440C0F935Q35088939-9A324BB1-F429-4D81-9838-4B4A6C690B5AQ35107181-B1583058-67AF-4D75-989A-FEA26650607BQ35438912-C4F067ED-003F-4FDC-B696-E7A72AF76C80Q35500124-2E983430-968D-4715-90CB-4DE826E75FACQ36092896-06EA1AD0-8E34-4941-BBAC-E2C22D33901EQ36276533-1C5A4C45-8BD1-409F-800C-BB48DA6D3AA2Q36390211-9985BD07-83A0-4087-8356-7A888B01A831Q36568428-094441A2-42C1-4C08-B70B-24532EF66997Q36596141-001D2631-6E99-49F5-A54A-14D2AAE1A39EQ36686638-9869FC79-7660-4B00-A28A-3ADC6A5C96FDQ36715918-F5B6B637-8831-4A07-B124-D39673E10156Q36801258-2F1DFD01-1287-4DC9-B090-4183E690AE4FQ36933964-61DC112F-E39C-4954-9195-DF2C5F75AB4EQ37114777-5AC3A91D-F73F-49E0-A80D-19821C872A16Q37182251-A0F9F79C-122F-4A35-99DE-FCED57277967Q37293241-6A223EF5-0962-4440-A36C-C5A22F991224Q37629006-F4B0EFD8-9817-4662-B132-D9A6A92E579AQ37636282-8C2EAB9A-01DF-4DC5-86D6-60F03CC8F4FFQ37677827-55009852-0AD0-4C21-B2DA-8D23586F939BQ37680218-6158AF10-CF0A-4EEA-9FBC-411DFFC96EBDQ37718566-CC6CC36A-FAE8-4C53-A076-7E5EF79F96BAQ38134726-7141F5E6-7DF3-4E82-92BE-786E4546B17F
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Purines, purinergic receptors, and cancer.
@ast
Purines, purinergic receptors, and cancer.
@en
Purines, purinergic receptors, and cancer.
@nl
type
label
Purines, purinergic receptors, and cancer.
@ast
Purines, purinergic receptors, and cancer.
@en
Purines, purinergic receptors, and cancer.
@nl
prefLabel
Purines, purinergic receptors, and cancer.
@ast
Purines, purinergic receptors, and cancer.
@en
Purines, purinergic receptors, and cancer.
@nl
P1433
P1476
Purines, purinergic receptors, and cancer.
@en
P2093
Francesco Di Virgilio
P304
P356
10.1158/0008-5472.CAN-12-1600
P407
P577
2012-10-22T00:00:00Z